CTHIn ForceLegislation
National Health (Pharmaceutical Benefits) Regulations 2017
83Information that must not be taken into account
Start here
Get a plain-English read of 83
Turn the raw legal text into a practical explanation grounded in National Health (Pharmaceutical Benefits) Regulations 2017.
#### 83 Information that must not be taken into account
(1) This Subdivision is made for the purposes of subsection 99ADB(6A) of the Act.
(2) Section 84 prescribes information that must not be taken into account in determining the weighted average disclosed price of a listed brand of a pharmaceutical item (the WADP brand) in respect of a data collection period.
(3) However, section 84 does not apply in relation to determining a weighted average disclosed price for the purposes of section 82.
(4) To avoid doubt, this Subdivision has effect:
(a) despite Subdivision B (weighted average disclosed price); and
(b) even if the information relates to the WADP brand.